Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Trovafloxacin mesylate

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Idiosyncratic adverse drug reactions (IADRs) occur in a small subset of patients, are unrelated to the pharmacological action of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2005
2005
Two new fluoroquinolones (trovafloxacin and sparfloxacin) with enhanced activity against gram-positive pathogens and two earlier… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
2003
2003
Purpose. Trovafloxacin is an expanded spectrum, newergeneration fluoroquinolone antibiotic with improved Gram-positive and… Expand
Is this relevant?
2001
2001
The main objective of this study was to develop an effective potentiometric saturation titration protocol for determining the… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
From 8,419 worldwide clinical isolates of Streptococcus pneumoniae obtained during 1997-1998, 69 isolates with reduced… Expand
  • table 1
  • table 2
Is this relevant?
2000
2000
To benchmark the activity of moxifloxacin, a European study comprising 900 Streptococcus pneumoniae, 1051 Haemophilus influenzae… Expand
Is this relevant?
1999
1999
Community-acquired pneumonia (CAP) can be caused by a variety of Gram-positive, Gram-negative, and atypical pathogens; however… Expand
  • figure 1
Is this relevant?
1998
1998
Tissue pharmacokinetics of trovafloxacin, a new broad-spectrum fluoroquinolone antimicrobial agent, were measured by positron… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1997
1997
Trovafloxacin, a broad-spectrum naphthyridone antimicrobial agent, was evaluated for potential phototoxicity in a standardized in… Expand
Is this relevant?
1996
1996
The pharmacokinetics of trovafloxacin [CP-99,219; 7-(3-azabicyclo[3.1.0]hexyl)-naphthyridone] were studied in rats, dogs, and… Expand
Is this relevant?